Apr. 29, 2013 ? A gas associated with the smell of rotten eggs has proven to effectively reduce joint swelling, in research which could lead to advances in the treatment of arthritis.
Scientists at the University of Exeter Medical School have discovered that a novel drug molecule, which slowly generates the gas hydrogen sulfide (H2S), effectively reduces swelling and inflammation in arthritic joints.
For years, H2S has been regarded as a highly poisonous by-product which is corrosive, flammable and explosive. But research is now showing an altogether more benign side to the substance.
Professor Matt Whiteman, of the University of Exeter Medical School, said the research, which is published online in the Journal of Cellular and Molecular Medicine, could pave the way for more effective treatments of arthritis and other inflammatory conditions. Prof Whiteman said: "H2S is widely dismissed as a toxic and foul-smelling environmental pollutant, but it has recently been shown to be created in humans and animals by a specific set of enzymes. Why would the body do this if it had no benefit? Our research has shown that the key to unlocking the therapeutic qualities of H2S is through slow release, mimicking the body's own production."
The team has previously shown that H2S levels were increased by up to four times in the knee joints of patients with joint diseases such as rheumatoid arthritis, but intriguingly the higher H2S levels strongly correlated with a lower number of inflammatory cells in the joint. The latest study provides further evidence that the real role for H2S may be to combat inflammation, swelling and joint destruction.
Prof Whiteman added: "A patient will usually visit their doctor with a joint already inflamed, swollen and painful. Since the compound worked after arthritis was established, it may be useful in treating arthritis in the future. Many compounds can prevent arthritis in the laboratory, but of course nobody knows when they will get arthritis. Having a class of compounds which reduce inflammation and swelling when arthritis is already active is extremely exciting. These molecules may also be useful in other inflammatory conditions, and even in the inflammatory aspects of diabetes and obesity."
The study was part of a large collaboration funded by the Wellcome Trust and Arthritis Research UK, involving Professor Philip K Moore and Dr Julie Keeble from King's College London, as well as researchers at the National University of Singapore and Queen's University Belfast. The team used primary human cells as well as a model of arthritis. Rheumatoid arthritis causes some cells to proliferate too quickly in the joint and secrete substances which promote tissue inflammation, swelling and eventually joint destruction. However, the H2S donor molecule prevented this secretion, and inhibited the activity of several enzymes which cause inflation. In the arthritis model, the compound did not prevent arthritis, but was highly effective at reducing joint inflammation and swelling once arthritis was established, suggesting H2S-based compounds may one day be useful in clinic.
The same team has previously found that people who are overweight or have diabetes have lower levels of H2S in their bodies than healthy adults resulting in higher blood pressure, poorer insulin sensitivity and higher levels of sugar in their blood. It has also been reported to promote ulcer healing and reduce lung injury in smokers.
Co-author Dr Mark E Wood, at the University of Exeter, added: "Despite its reputation for being hazardous, H2S could in fact hold the key to solving some of the widespread health problems affecting the country. Our work is a major step in proving that it can be more hero than villain to the human body, providing it is administered in the right way, at the right time. We currently have several more efficient H2S donor molecules being evaluated with collaborators and this is a very exciting time for us."
Dr Julie Keeble, co-author from King's College London, commented: "The finding that H2S is able to reduce joint inflammation in experimental models makes it a very exciting prospect for treating arthritis. Many patients with arthritis do not respond effectively to current treatments or suffer side-effects from their medication. We hope that H2S-releasing drugs like the one tested in this study will be effective in treating arthritis without uncomfortable side effects."
Prof Whiteman is organising the Second European Conference on the Biology of Hydrogen Sulfide at the University of Exeter between September 8 and 11. It will bring together European scientists and participants from across the world to focus on the rapidly expanding and exciting field of H2S biology and medicine.
Share this story on Facebook, Twitter, and Google:
Other social bookmarking and sharing tools:
Story Source:
The above story is reprinted from materials provided by University of Exeter.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Journal Reference:
- Ling Li, Bridget Fox, Julie Keeble, Manuel Salto-Tellez, Paul G. Winyard, Mark E. Wood, Philip K. Moore, Matthew Whiteman. The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells. Journal of Cellular and Molecular Medicine, 2013; 17 (3): 365 DOI: 10.1111/jcmm.12016
Note: If no author is given, the source is cited instead.
Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/~3/qI-kKaKsjkU/130429130516.htm
shaka smart hungergames bagpipes aspirin aspirin 21 jump street illinois primary results
![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 29-Apr-2013
Share ] 
Once you’ve had a few drinks at a bar it’s easy to let loose and blow off steam. Unfortunately, while you’re having fun, you could end up annoying others around you, namely the staff at the venue you’re at. By acting like a fool, you’re jeopardizing your future visits, since bartenders tend to remember who was a jerk and who was a great customer. A project at our Disrupt Hackathon called “Bar Power” is an app that will remind you to “not be a douchebag.” It’s somewhat of a game, walking you through nice things to do when you enter a bar. For example, the app will suggest that you say “hi” to the bartender and introduce yourself. If you do it and mark it?down in the app, you get some karma points. The really interesting part of the app comes into play when you’ve done something wrong. Did you drop a glass? Fall down? Mark that down, too. Naturally, you’ll lose those karma points that you gained by being the perfect customer. I chatted with the team who built it, Patricia Ju and Chris Baily, and they discussed their reasons for creating Bar Power, mostly stemming from Baily’s professional experience in the bar scene. While Bar Power might complicate what you’ve set out to do, which is drink, it is a good way to have a little fun and learn how to be a better customer. Ju explained: “It’s so much better to go out to places where you know people. Bartenders gave us feedback and that helped us make Bar Power’s rules. Once you’re in the app, you select the bar that you’re at and then start doing the nice things that it tells you to do. Slip up? Check that off on the list, too: The map below will track how you’re doing throughout the city, alerting you to areas that you should avoid since you were a freaking jerk the night before: As Baily explained, if people understand what to do and what not to do from the bartender community, their experience will be a better one. If the team can build relationships with venues to get them to interact with customers through the app, this could be a neat rating system that goes both ways, ? la?apps like Lyft and Uber. It sounds like Bar Power has potential past being “just a hack,” and I